Family facts
IDVParent PIIDSPE2DB20D9331
Also listed asSPE2DB-20-D-9331
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Period endOct 30, 2025
IDV obligated$16.8M
Child awards91
Places of performance
StatesIL
Distinctive task orders
12SPE2DB24FL1P0 — 4565391864!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $482K · PoP Aug 28, 2024
SPE2DB22FL1D0 — 4557634397!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $473K · PoP Jul 14, 2022
SPE2DB22FL1L9 — 4558490756!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $473K · PoP Oct 6, 2022
SPE2DB23FL0V5 — 4560373828!ENTYVIO 300 MG VIALS
Dms Pharmaceutical Group Inc. · $462K · PoP Apr 12, 2023
SPE2DB21FL1W1 — 4554925869!XOLAIR 150 MG/1.2 ML POWDER VLS
Dms Pharmaceutical Group Inc. · $447K · PoP Oct 7, 2021
SPE2DB24FL0T0 — 4563825822!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $401K · PoP Mar 19, 2024
SPE2DB25FL2C7 — 4569663788!STELARA 90 MG/ML SYRINGEML
Dms Pharmaceutical Group Inc. · $388K · PoP Oct 20, 2025
SPE2DB25FL2C6 — 4569804201!STELARA 90 MG/ML SYRINGEML
Dms Pharmaceutical Group Inc. · $388K · PoP Oct 20, 2025
SPE2DB23FL1M3 — 4562050381!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $388K · PoP Sep 22, 2023
SPE2DB25FL0R9 — 4567268553!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $328K · PoP Mar 5, 2025
SPE2DB25FL2C4 — 4569633644!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $328K · PoP Oct 20, 2025
SPE2DB23FL0U7 — 4560287161!KEYTRUDA 100 MG/4 ML VIAL 4ML
Dms Pharmaceutical Group Inc. · $310K · PoP Apr 4, 2023
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly
